Jinnam Kim

Jinnam Kim

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2024 in Science Immunology
Verified
Journal Article
Closed access
SKSang-Hoon Kim
Sang-Hoon Kim
JKJihye Kim
Jihye Kim
SJSungmin Jung
Sungmin Jung
JNJi Yun Noh
Ji Yun Noh
JKJinnam Kim
Jinnam Kim
ESEui-Cheol Shin
Eui-Cheol Shin
Here, we examine peripheral blood memory T cell responses against the SARS-CoV-2 BA.4/BA.5 variant spike among vaccinated individuals with or without Omicron breakthrough infections. We provide evidence supporting a lack of original antigenic sin in CD8 + T cell responses targeting the spike. We show that BNT162b2-induced memory T cells respond to the BA.4/BA.5 spike. Among individuals with BA.1/BA.2 breakthrough infections, IFN-γ–producing CD8 + T cell responses against the BA.4/BA.5 spike increased. In a subgroup with BA.2 breakthrough infections, IFN-γ–producing CD8 + T cell responses against the BA.2-mutated spike region increased and correlated directly with responses against the BA.4/BA.5 spike, indicating that BA.2 spike–specific CD8 + T cells elicited by BA.2 breakthrough infection cross-react with the BA.4/BA.5 spike. We identified CD8 + T cell epitope peptides that are present in the spike of BA.2 and BA.4/BA.5 but not the original spike. These peptides are fully conserved in the spike of now-dominant XBB lineages. Our study shows that breakthrough infection by early Omicron subvariants elicits CD8 + T cell responses that recognize epitopes within the spike of newly emerging subvariants.

1 June 2020
Verified
Conference Paper
Closed access
SSSeongmin Son
Seongmin Son
JMJunhong Min
Junhong Min
EJEunsuk Jung
Eunsuk Jung
HKHoechul Kim
Hoechul Kim
TKTaeyoung Kim
Taeyoung Kim
GYGeun Young Yeom
Geun Young Yeom
The low-temperature wafer bonding has been studied on two types of dielectric material (SiO, SiCN) as final bonding layers. It is important for the wafer bonding technology to obtain the higher interfacial energy between two bonding wafers, and oxygen and nitrogen (O 2 , N 2 ) plasma treatments have been studied to properly activate the dielectric film surfaces prior to a bonding process that includes chemical-mechanical polishing, hydration with DI water and heat treatment. The surface activation by the plasma treatments with DI hydration formed ~ 10nm thick SiO x layer on the SiCN films. It is found that a newly formed surface SiOx layer played a role as a bonding medium. The dielectric film surfaces were treated by plasma treatment, then characterized by analyzing chemical binding states in the surface SiO x layer. The characteristics of the new SiO x layers were found to be dependent on the plasma species and bulk dielectric films. The obtained properties of the surface layer have been co-related to the initial bonding energy of the bonded wafers as well as the final bonding energy with heat treatment. As a result, the N 2 plasma treatment to the dielectric films enhanced the initial bonding energy and SiCN-SiCN bonding wafers treated by the O 2 plasma have the better initial bonding energy rather than SiO-SiO bonding due to high hydrogen contents in the surface oxide films. In addition, the chemical analysis (XPS) has revealed the surface activity of the films from the results of the chemical binding states of Si. Basically, we focus on the initial bonding energy and it is crucial to ensure that the Cu pads facing each other comes into contact prior to the heat treatment that causes Cu diffusion across the opposite Cu pads.

11 April 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JKJung Ho Kim
Jung Ho Kim
JKJinnam Kim
Jinnam Kim
WLWoon Ji Lee
Woon Ji Lee
HSHye Seong
Hye Seong
HCHeun Choi
Heun Choi
SNSung Hoon Noh
Sung Hoon Noh
Recent studies have shown that body composition is an important factor that affects surgical site infection (SSI). However, each study has utilized different body composition criteria. Therefore, in this study, we aim to determine the most predictable body composition criteria for the prediction of SSI after gastrectomy. The visceral fat area (VFA), subcutaneous fat area (SFA), and muscle area were assessed by a preoperative-stage computed tomographic (CT) scan. To compare the predictive performance of body composition for SSI, logistic regression models were used, and the models were compared using the receiver operation characteristic (ROC) curve and the area under the curve (AUC) value. Of the 1038 eligible patients, 58 patients (5.6%) developed SSI. The VFA-to-SFA ratio showed the best predictive performance (mean AUC 75.11). The cutoff value for the SSI of the VFA-to-SFA ratio was 0.94, and the sensitivity and specificity were 67.86% and 77.65%, respectively. A multivariate logistic analysis indicated that a total gastrectomy (OR, 2.13; p = 0.017), stage III or IV cancer (OR, 2.66; p = 0.003), and a high VFA-to-SFA ratio (OR, 8.09; p < 0.001) were independent risk factors for SSI after gastrectomy. The VFA-to-SFA ratio is the most predictable body composition model for use in predicting the incidence of SSI after gastrectomy.

18 November 2022 in Viruses
Verified
Journal Article
Open access
PDF file
KLKi Hyun Lee
Ki Hyun Lee
JKJinnam Kim
Jinnam Kim
JLJung Ah Lee
Jung Ah Lee
CKChang Hyup Kim
Chang Hyup Kim
JAJin Young Ahn
Jin Young Ahn
JKJung Ho Kim
Jung Ho Kim
Most studies on the real-world effectiveness and safety of dolutegravir/lamivudine (DTG/3TC) have been conducted in Western countries, and Asian reports are lacking. We evaluated the effectiveness and safety of DTG/3TC in Korean adult people living with HIV (PLWH). This retrospective study was conducted from July 2020 to July 2022 at a tertiary hospital in Korea. Those who were followed up for more than 12 months were included. We analyzed the baseline characteristics, effectiveness, resistant profiles, body weights, metabolic parameters, and safety of DTG/3TC treatment in 151 PLWH, dividing them into the treatment-naïve group and the switching group. The median DTG/3TC treatment durations in the treatment-naïve and switching groups were 507.5 and 525.0 days. In the treatment-naïve group, the viral RNA titer was undetectable at 6 and 12 months in 95% of patients. In the switching group, virologic suppression was well-maintained. Meanwhile, the creatinine levels were slightly elevated in both groups compared to baseline. Five participants complained of mild side effects, such as indigestion, constipation, diarrhea, and fatigue. However, no patient stopped treatment during the follow-up period. Since there was no virological failure or serious complications observed in this study, DTG/3TC may be a good treatment option for PLWH in Korea.

1 April 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
JKJinnam Kim
Jinnam Kim
CKChanghyup Kim
Changhyup Kim
JLJung Ah Lee
Jung Ah Lee
SLSE JU LEE
SE JU LEE
KLKi Hyun Lee
Ki Hyun Lee
JCJun Yong Choi
Jun Yong Choi
This study investigated the immunogenicity of, and reactogenicity to, the ChAdOx1 nCoV-19 vaccine according to pre-existing adenovirus immunity. Individuals scheduled for COVID-19 vaccination were prospectively enrolled in a tertiary hospital with 2400 beds from March 2020 onwards. Pre-existing adenovirus immunity data was obtained before ChAdOx1 nCoV-19 vaccination. A total of 68 adult patients administered two doses of the ChAdOx1 nCoV-19 vaccine were enrolled. Pre-existing adenovirus immunity was identified in 49 patients (72.1%), but not in the remaining 19 patients (27.9%). The geometric mean titer of S-specific IgG antibodies was statistically higher in individuals without pre-existing adenovirus immunity at several time points: before the second ChAdOx1 nCoV-19 dose (56.4 (36.6–125.0) vs. 51.0 (17.9–122.3), p = 0.024), 2–3 weeks after the second ChAdOx1 nCoV-19 dose (629.5 (451.5–926.5) vs. 555.0 (287.3–926.0), p = 0.049), and 3 months after the second ChAdOx1 nCoV-19 dose (274.5 (160.5–655.3) vs. 176.0 (94.3–255.3), p = 0.033). In the absence of pre-existing adenovirus immunity, systemic events were observed with higher frequency, especially chills (73.7% vs. 31.9%, p = 0.002). In conclusion, individuals without pre-existing adenovirus immunity showed a higher immune response to ChAdOx1 nCoV-19 vaccination and a higher frequency of reactogenicity to ChAdOx1 nCoV-19 vaccination was observed.

1 January 2024 in Infection & Chemotherapy
Verified
Journal Article
Open access
KLKi Hyun Lee
Ki Hyun Lee
JKJinnam Kim
Jinnam Kim
JLJung Ah Lee
Jung Ah Lee
CKChang Hyup Kim
Chang Hyup Kim
OKOh Mi Kwon
Oh Mi Kwon
JCJun Yong Choi
Jun Yong Choi
Lee KH, et al. Infect Chemother. 2024 Mar;56:e14. https://doi.org/10.3947/ic.2023.0091